Edition:
United States

Profile: Trinity Biotech PLC (TRIB.O)

TRIB.O on Nasdaq

5.48USD
3:59pm EDT
Change (% chg)

$-0.08 (-1.44%)
Prev Close
$5.56
Open
$5.43
Day's High
$5.55
Day's Low
$5.39
Volume
30,374
Avg. Vol
45,961
52-wk High
$13.34
52-wk Low
$5.11

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.

Company Address

Trinity Biotech PLC

IDA Business Park
BRAY     18
P: +3531.2769800
F: +3531.2769888

Company Web Links